Neurodegenerative diseases (NDs) represent a heterogeneous group of aging-related
disorders featured by progressive impairment of motor and/or cognitive functions, often …

Alzheimer's disease (AD), the most common form of dementia, is a progressive and
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …

Parkinson's disease is a neurodegenerative disease, the treatment of which is mainly
centred around supplementation of dopamine. Additional targets have been identified and …

Parkinson disease (PD) is the second most common neurodegenerative disorder, whose
prevalence is 2~ 3% in the population over 65. α‐Synuclein aggregation is the major …

Parkinson's disease (PD) is one of the most common neurodegenerative disorders that is
implicated in aging populations. As numerous developed nations are experiencing …

Several transport vectors, including nanoparticles, have been reported to be used for the
delivery of therapeutic medicines crossing the impermeable blood-brain barrier (BBB) to …

Parkinson's disease (PD) is a progressive neurological disorder, in which dopaminergic
midbrain neurons degenerate, leading to dopamine depletion that is associated with …

Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's
disease (PD), affect the ageing population worldwide and while severely impairing the …

Parkinson's disease (PD) is a devastating neurodegenerative disease characterized by
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …

Background: We had previously synthetized a macromolecular prodrug consisting of
oxidized Alginate and dopamine (AlgOx-Da) for a potential application in Parkinson disease …